Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Lymphoma, Large-Cell, Anaplastic 1Lymphoma, Large B-Cell, Diffuse 1Gastroesophageal Reflux 1Burkitt Lymphoma 1Barrett Esophagus 1

Interventions

Endoscopy, Digestive System 4Esomeprazole 3Biopsy 3YF 476 2Specimen Handling 2Proton Pump Inhibitors 2Lansoprazole 2Endoscopy 2plecanatide 1omeprazole, sodium bicarbonate drug combination 1linaclotide 1ilaprazole 1Surveys and Questionnaires 1Rabeprazole 1Proflavine 1Lysine Acetyltransferase 5 1Gastropexy 1Gastroenterostomy 1Gastric Bypass 1Fundoplication 1Fluorescein 1Endoscopic Mucosal Resection 1Endoscopes 1Diet, Gluten-Free 1Dexlansoprazole 1Anastomosis, Roux-en-Y 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Gastroesophageal Reflux × omeprazole, sodium bicarbonate drug combination × Clear all
NCT01129778 2017-06-06

Assessment of Zegerid on Esophageal pH in Patients With Barrett's Esophagus

Stanford University

Phase NA Terminated
27 enrolled 6 charts
Gastrointestinal

Barrett Esophagus, Gastroesophageal Reflux

Data powered by HemOnc (CC BY 4.0) Colophon âš¡